Xiamen Amoytop Biotech Co.,Ltd.’s Net Profit Rose 46.5% in First Quarter of 2023

Xiamen Amoytop Biotech Co.,Ltd. (厦门特宝生物工程股份有限公司) (688278.SH) reported a net profit of 84.2 million yuan in the first quarter of 2023, up 46.5% year-on-year.

Meanwhile, the company posted 419.3 million yuan in revenue, up 21.5% year-on-year.

At the end of the reporting period, it had 1.8 billion yuan in total assets and 353.2 million yuan in total liabilities, with a liability-to-asset ratio of 19.2%.